Differences in Pulmonary and Extra-Pulmonary Traits between Women and Men with Chronic Obstructive Pulmonary Disease.
COPD
gender
sex-related differences
treatable traits
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
26 Jun 2022
26 Jun 2022
Historique:
received:
10
05
2022
revised:
11
06
2022
accepted:
23
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
Background: Evidence suggests sex-related differences in chronic obstructive pulmonary disease (COPD). Whether these differences are reflected in the prevalence of treatable traits remains unknown. Methods: Two samples of patients referred to secondary (n = 530) or tertiary care (n = 2012) were analyzed. Men and women were matched for age, forced expiratory volume in 1 s and body mass index. Sex-related differences were tested using t-tests, Mann-Whitney U, or chi-square tests. Results: Frequent exacerbations (30.5 vs. 19.7%), high cardiovascular risk (88.1 vs. 66.2%) and activity-related severe dyspnea (50.9 vs. 34.8%) were more prevalent in women in secondary care (p < 0.05). Severe hyperinflation (43.0 vs. 25.4%), limited diffusing capacity (79.6 vs. 70.1%), impaired mobility (44.0 vs. 28.7%), frequent exacerbations (66.8 vs. 57.4%), frequent hospitalizations (47.5 vs. 41.6%), severe activity-related dyspnea (89.1 vs. 85.0%), symptoms of anxiety (56.3 vs. 42.0%) and depression (50.3 vs. 44.8%), and poor health status (79.9 vs. 71.0%) were more prevalent in women in tertiary care (p < 0.05). Severe inspiratory muscle weakness (14.6 vs. 8.2%) and impaired exercise capacity (69.1 vs. 59.6%) were more prevalent among men (p < 0.05) in tertiary care. Conclusions: Sex-related differences were found, with most traits more prevalent and severe among women. Care providers should be aware of these differences to adjust treatment.
Identifiants
pubmed: 35806965
pii: jcm11133680
doi: 10.3390/jcm11133680
pmc: PMC9267757
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ciro
ID : Ciro+ Short-term Research Training Fellowship 2021
Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BD/146134/2019
Organisme : Fundação para a Ciência e Tecnologia
ID : UIDB/04501/2020
Références
Eur Respir J. 2005 Sep;26(3):511-22
pubmed: 16135736
BMC Public Health. 2012 Aug 02;12:598
pubmed: 22856611
Chest. 2001 Jun;119(6):1691-5
pubmed: 11399692
Aust N Z J Public Health. 2001 Oct;25(5):464-9
pubmed: 11688629
Int J Chron Obstruct Pulmon Dis. 2018 Oct 01;13:3021-3029
pubmed: 30319250
J Clin Med. 2019 Mar 11;8(3):
pubmed: 30862102
Int J Chron Obstruct Pulmon Dis. 2014 Oct 14;9:1145-54
pubmed: 25342899
Int J Chron Obstruct Pulmon Dis. 2020 Apr 23;15:903-919
pubmed: 32425516
Int J Chron Obstruct Pulmon Dis. 2020 Sep 22;15:2217-2224
pubmed: 33061339
Pulmonology. 2021 Jul-Aug;27(4):366-368
pubmed: 32739325
Eur Respir J. 2019 Jun 13;53(6):
pubmed: 30956204
ERJ Open Res. 2020 Nov 02;6(4):
pubmed: 33263050
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
COPD. 2007 Sep;4(3):225-36
pubmed: 17729066
NPJ Prim Care Respir Med. 2017 Dec;27(1):11
pubmed: 28202995
Respir Med. 2006 Oct;100(10):1767-74
pubmed: 16531031
J Thorac Dis. 2018 May;10(Suppl 12):S1390-S1399
pubmed: 29928521
J Thorac Dis. 2015 Oct;7(10):1765-73
pubmed: 26623099
Eur Respir J. 2015 Dec;46(6):1625-35
pubmed: 26453626
Am J Clin Nutr. 1998 Dec;68(6):1298-303
pubmed: 9846862
Eur Respir Rev. 2019 Dec 18;28(154):
pubmed: 31852745
PLoS One. 2012;7(6):e39198
pubmed: 22745715
BMJ Open. 2013 Aug 05;3(8):
pubmed: 23921069
Eur Respir J. 2016 Jul;48(1):46-54
pubmed: 27076595
ERJ Open Res. 2021 May 31;7(2):
pubmed: 34084787
Multidiscip Respir Med. 2015 Aug 05;10(1):24
pubmed: 26246895
J Appl Physiol (1985). 2019 Mar 1;126(3):607-615
pubmed: 30496707
Lancet. 2017 Sep 2;390(10098):988-1002
pubmed: 28872031
Eur Respir J. 2019 May 9;53(5):
pubmed: 30846468
Chest. 1988 Mar;93(3):580-6
pubmed: 3342669
Medicine (Baltimore). 2016 Jul;95(28):e4225
pubmed: 27428228
Br J Clin Pharmacol. 2012 Sep;74(3):396-410
pubmed: 22348281
Respiration. 2019;97(6):548-557
pubmed: 30836374
Eur Respir Rev. 2021 Nov 8;30(162):
pubmed: 34750114
Thorax. 1999 Dec;54(12):1119-38
pubmed: 10567633
Eur Respir J. 2005 Nov;26(5):948-68
pubmed: 16264058
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Chest. 2005 Oct;128(4):2012-6
pubmed: 16236849
Health Qual Life Outcomes. 2003 Apr 28;1:13
pubmed: 12773199
Am J Cardiol. 1994 Mar 1;73(7):460-8
pubmed: 8141087
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Eur J Clin Nutr. 2020 Aug;74(8):1181-1191
pubmed: 32123345
J Cardiopulm Rehabil. 2003 Mar-Apr;23(2):143-50
pubmed: 12668937
Int J Chron Obstruct Pulmon Dis. 2018 May 10;13:1507-1514
pubmed: 29785100
Eur Respir J. 2017 Jan 3;49(1):
pubmed: 28049168
Am Rev Respir Dis. 1969 May;99(5):696-702
pubmed: 5772056
Am Rev Respir Dis. 1985 Jul;132(1):42-7
pubmed: 4014871
Lancet. 2020 Jul 11;396(10244):97-109
pubmed: 32445693
Int J Chron Obstruct Pulmon Dis. 2019 May 07;14:961-969
pubmed: 31123398
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Eur Respir J. 1999 Aug;14(2):270-4
pubmed: 10515400
J Psychosom Res. 2017 Jul;98:40-46
pubmed: 28554371
Int J Behav Nutr Phys Act. 2011 Jul 28;8:80
pubmed: 21798044
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809
BMJ Open. 2018 Apr 10;8(4):e021745
pubmed: 29643168
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Respir Res. 2019 Aug 22;20(1):191
pubmed: 31439045
J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24
pubmed: 29169740
Chest. 2019 Jul;156(1):80-91
pubmed: 31034818
Int J Chron Obstruct Pulmon Dis. 2019 Nov 05;14:2469-2478
pubmed: 31806956